| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YJMCC.2016.09.007 |
| P698 | PubMed publication ID | 27639308 |
| P2093 | author name string | Ali El-Armouche | |
| Silvio Weber | |||
| Stefanie Meyer-Roxlau | |||
| P2860 | cites work | Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association | Q22306356 |
| Phosphorylation of protein phosphatase inhibitor-1 by Cdk5 | Q24091381 | ||
| Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1. | Q24291713 | ||
| Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2 | Q24293501 | ||
| Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor | Q24324682 | ||
| Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1 | Q24532150 | ||
| Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases | Q26776182 | ||
| Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure | Q27318604 | ||
| Development of a Peptide that Selectively Activates Protein Phosphatase-1 in Living Cells | Q27672858 | ||
| Inotropes. | Q27692096 | ||
| Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes | Q28201819 | ||
| Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy | Q28235610 | ||
| Physiologic importance of protein phosphatase inhibitors | Q28281368 | ||
| Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure | Q28305791 | ||
| Is myosin phosphatase regulated in vivo by inhibitor-1? Evidence from inhibitor-1 knockout mice | Q28344007 | ||
| ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardi | Q55037837 | ||
| Update of the guidelines on sudden cardiac death of the European Society of Cardiology | Q58010887 | ||
| Synthetic peptides reproducing the site phosphorylated by cAMP-dependent protein kinase in protein phosphatase inhibitor-1. Effect of structural modifications on the phosphorylation efficiency | Q58037679 | ||
| Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1 | Q64378890 | ||
| Partial structure and hormonal regulation of rabbit liver inhibitor-1; distribution of inhibitor-1 and inhibitor-2 in rabbit and rat tissues | Q69938842 | ||
| Rabbit muscle glycogen-bound phosphoprotein phosphatases: Substrate specificities and effects of inhibitor-1 | Q70173684 | ||
| Isolation and characterisation of active fragments of protein phosphatase inhibitor-1 from rabbit skeletal muscle | Q70511831 | ||
| Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts | Q72933722 | ||
| Increased expression of cardiac phosphatases in patients with end-stage heart failure | Q73088339 | ||
| Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice | Q73699441 | ||
| Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation | Q73782374 | ||
| Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts | Q75294807 | ||
| Letter to the editor: backbone 1H, 15N, and 13C resonance assignments of inhibitor-1--a protein inhibitor of protein phosphatase-1 | Q77445658 | ||
| Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts | Q79289596 | ||
| Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation | Q80071126 | ||
| Phosphorylation of human inhibitor-1 at Ser67 and/or Thr75 attenuates stimulatory effects of protein kinase A signaling in cardiac myocytes | Q80117041 | ||
| THE SYNTHESIS OF A POLYSACCHARIDE FROM GLUCOSE-1-PHOSPHATE IN MUSCLE EXTRACT | Q80873959 | ||
| Reduced inhibitor 1 and 2 activity is associated with increased protein phosphatase type 1 activity in left ventricular myocardium of one-kidney, one-clip hypertensive rats | Q81565804 | ||
| The effect of PKA-phosphorylation on the structure of inhibitor-1 studied by NMR spectroscopy | Q84842182 | ||
| Research advances in heart failure: a compendium | Q87150620 | ||
| Epidemiology of heart failure | Q87330478 | ||
| Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy. | Q48118068 | ||
| Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase | Q48628901 | ||
| Phospholemman-dependent regulation of the cardiac Na/K-ATPase activity is modulated by inhibitor-1 sensitive type-1 phosphatase | Q48756558 | ||
| Isoform-specific roles of protein phosphatase 1 catalytic subunits in sarcoplasmic reticulum-mediated Ca2+ cycling | Q50545091 | ||
| A kinetic analysis of the effects of inhibitor-1 and inhibitor-2 on the activity of protein phosphatase-1. | Q52433415 | ||
| Potential of protein phosphatase inhibitor 1 as biomarker of pancreatic β-cell injury in vitro and in vivo | Q28575315 | ||
| Adenovirus-delivered short hairpin RNA targeting PKCalpha improves contractile function in reconstituted heart tissue | Q28581250 | ||
| PKC-alpha regulates cardiac contractility and propensity toward heart failure | Q28589911 | ||
| Inhibitor-1 is not required for the activation of glycogen synthase by insulin in skeletal muscle | Q30304137 | ||
| Manipulating cardiac contractility in heart failure: data from mice and men. | Q30888971 | ||
| Identification of a novel phosphorylation site in protein phosphatase inhibitor-1 as a negative regulator of cardiac function. | Q33260648 | ||
| Role of RyR2 phosphorylation in heart failure and arrhythmias: Controversies around ryanodine receptor phosphorylation in cardiac disease | Q33561848 | ||
| Cardiac adrenergic control and atrial fibrillation | Q33792556 | ||
| Role of inotropic agents in the treatment of heart failure. | Q33816527 | ||
| beta-adrenergic receptor blockade in chronic heart failure | Q33831388 | ||
| Impaired local regulation of ryanodine receptor type 2 by protein phosphatase 1 promotes atrial fibrillation. | Q34048290 | ||
| The human G147D-protein phosphatase 1 inhibitor-1 polymorphism is not associated with altered clinical characteristics in heart failure | Q34051035 | ||
| Inhibition of cardiomyocyte hypertrophy by protein arginine methyltransferase 5 | Q34107266 | ||
| Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study | Q34117950 | ||
| Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis | Q34169287 | ||
| Type 1 phosphatase, a negative regulator of cardiac function | Q34281889 | ||
| The inhibitor-1 C terminus facilitates hormonal regulation of cellular protein phosphatase-1: functional implications for inhibitor-1 isoforms | Q34345574 | ||
| The BioPlex Network: A Systematic Exploration of the Human Interactome | Q34485581 | ||
| The large isoforms of A-kinase anchoring protein 18 mediate the phosphorylation of inhibitor-1 by protein kinase A and the inhibition of protein phosphatase 1 activity. | Q34700997 | ||
| Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure | Q34786205 | ||
| Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy | Q35047672 | ||
| Active inhibitor-1 maintains protein hyper-phosphorylation in aging hearts and halts remodeling in failing hearts | Q35061110 | ||
| Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. | Q35126445 | ||
| Phosphorylation of protein phosphatase inhibitor-1 by protein kinase C. | Q35158657 | ||
| Guanabenz interferes with ER stress and exerts protective effects in cardiac myocytes | Q35180639 | ||
| What is the role of beta-adrenergic signaling in heart failure? | Q35582718 | ||
| Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure. | Q35601874 | ||
| Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor | Q35750011 | ||
| Structural basis for protein phosphatase 1 regulation and specificity | Q35954007 | ||
| Epidemiology and genetics of sudden cardiac death | Q36102464 | ||
| Cardiac-specific deletion of protein phosphatase 1β promotes increased myofilament protein phosphorylation and contractile alterations | Q36260328 | ||
| Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation | Q36331025 | ||
| Skeletal muscle Nur77 expression enhances oxidative metabolism and substrate utilization | Q36387279 | ||
| Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. | Q36391033 | ||
| Human G109E-inhibitor-1 impairs cardiac function and promotes arrhythmias | Q36399731 | ||
| Neurohumoral activation in heart failure: the role of adrenergic receptors. | Q36579463 | ||
| Constitutive phosphorylation of inhibitor-1 at Ser67 and Thr75 depresses calcium cycling in cardiomyocytes and leads to remodeling upon aging | Q36653535 | ||
| Cardiac beta-adrenergic signaling: from subcellular microdomains to heart failure | Q36667350 | ||
| AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling | Q36707489 | ||
| Assisted circulation: experience with the Novacor Left Ventricular Assist System | Q37012970 | ||
| Detailed structural characterization of unbound protein phosphatase 1 inhibitors | Q37105049 | ||
| Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology | Q37276968 | ||
| A human polymorphism of protein phosphatase-1 inhibitor-1 is associated with attenuated contractile response of cardiomyocytes to beta-adrenergic stimulation | Q37357819 | ||
| Beta-adrenergic stimulation and myocardial function in the failing heart | Q37358922 | ||
| Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury. | Q37364808 | ||
| From the ryanodine receptor to cardiac arrhythmias. | Q37576978 | ||
| Protein phosphatase 1 inhibitor-1 deficiency reduces phosphorylation of renal NaCl cotransporter and causes arterial hypotension | Q37604706 | ||
| The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications | Q37799958 | ||
| Phosphatase-1 inhibitor-1 in physiological and pathological β-adrenoceptor signalling | Q37847537 | ||
| Proarrhythmic atrial calcium cycling in the diseased heart. | Q37997720 | ||
| Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application | Q38023611 | ||
| Function and regulation of serine/threonine phosphatases in the healthy and diseased heart. | Q38139729 | ||
| The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical Perspective. | Q38443752 | ||
| Omecamtiv mecarbil: a new cardiac myosin activator for the treatment of heart failure | Q38639973 | ||
| Separation and Characterization of Two Phosphorylase Phosphatase Inhibitors from Rabbit Skeletal Muscle | Q40038892 | ||
| The Purification and Characterization of Protein Phosphatase Inhibitor-1 from Rabbit Skeletal Muscle | Q40140086 | ||
| Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart | Q41131436 | ||
| Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure? | Q41397431 | ||
| Identification of novel genes for glucose metabolism based upon expression pattern in human islets and effect on insulin secretion and glycemia | Q41712998 | ||
| CaMKIIδ mediates β-adrenergic effects on RyR2 phosphorylation and SR Ca(2+) leak and the pathophysiological response to chronic β-adrenergic stimulation. | Q42114357 | ||
| Distribution of protein phosphatase inhibitor-1 in brain and peripheral tissues of various species: comparison with DARPP-32. | Q42453251 | ||
| Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes | Q42496811 | ||
| Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation | Q42514701 | ||
| Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosis | Q42734340 | ||
| Inhibition of Elevated Ca 2+ /Calmodulin-Dependent Protein Kinase II Improves Contractility in Human Failing Myocardium | Q42918992 | ||
| Testosterone modulates gene expression pathways regulating nutrient accumulation, glucose metabolism and protein turnover in mouse skeletal muscle. | Q43093699 | ||
| Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure | Q43266247 | ||
| Development of phosphatase inhibitor-1 peptides acting as indirect activators of phosphatase 1. | Q43570941 | ||
| Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. | Q43805158 | ||
| Protein phosphatase 1 is a molecular constraint on learning and memory. | Q44116526 | ||
| Up-regulation of micro-RNA765 in human failing hearts is associated with post-transcriptional regulation of protein phosphatase inhibitor-1 and depressed contractility | Q45353933 | ||
| Synergistic role of protein phosphatase inhibitor 1 and sarco/endoplasmic reticulum Ca2+ -ATPase in the acquisition of the contractile phenotype of arterial smooth muscle cells | Q45858131 | ||
| Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy | Q46438826 | ||
| Defective cardiac ryanodine receptor regulation during atrial fibrillation | Q46455370 | ||
| Genome-wide analysis of gene expression during adipogenesis in human adipose-derived stromal cells reveals novel patterns of gene expression during adipocyte differentiation | Q46760205 | ||
| Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure | Q46790561 | ||
| Long-term beta-adrenergic stimulation leads to downregulation of protein phosphatase inhibitor-1 in the heart | Q46962473 | ||
| P304 | page(s) | 116-126 | |
| P577 | publication date | 2016-09-14 | |
| P1433 | published in | Journal of Molecular and Cellular Cardiology | Q2061932 |
| P1476 | title | Role of protein phosphatase inhibitor-1 in cardiac beta adrenergic pathway | |
| P478 | volume | 101 |
| Q61807422 | Age-Dependent Protein Expression of Serine/Threonine Phosphatases and Their Inhibitors in the Human Cardiac Atrium |
| Q90590745 | Functions and therapeutic potential of protein phosphatase 1: Insights from mouse genetics |
| Q92309402 | Inhibitor 1 of Protein Phosphatase 1 Regulates Ca2+/Calmodulin-Dependent Protein Kinase II to Alleviate Oxidative Stress in Hypoxia-Reoxygenation Injury of Cardiomyocytes |
| Q92582770 | On inotropic effects of UTP in the human heart |
| Q39263982 | Raf kinase inhibitor protein: lessons of a better way for β-adrenergic receptor activation in the heart. |
| Q38771731 | Serine/Threonine Phosphatases in Atrial Fibrillation |
Search more.